HeartSentry

3 stories · following the connections

Business

Lexington Recieves Approval to Commence Clinical Study

By Nasdaq OMXJan 24, 2018, 2:00 PM UTC

Business

Lexington Completes IRB Submission in Preparation for Clinical Study

By Nasdaq OMXJan 18, 2018, 2:01 PM UTC

Business

Lexington Biosciences Announces Exercise of Warrants

By Nasdaq OMXJan 11, 2018, 2:01 PM UTC